Tag: relapse of MS

Vascular Comorbidity in MS Linked to Atrophy, Functional Decline

Vascular comorbidities, including diabetes and hypertension, are linked to significantly lower measures of neurologic function in people with multiple sclerosis (MS) vs patients without these...

Serum NfL May Flag Subclinical Disease in Pregnant MS Patients

Among women with multiple sclerosis (MS), levels of serum neurofilament light (sNfL) are higher during pregnancy and the postpartum period. The increase in sNfL is...

Masitinib Impresses in ‘Nonactive’ Progressive MS

The investigational drug, masitinib (AB Science), which has a completely new mechanism of action for multiple sclerosis (MS), has shown a positive result in slowing...

FDA OKs Ofatumumab (Kesimpta) for Relapsing Forms of MS

The US Food and Drug Administration (FDA) has approved ofatumumab injection (Kesimpta, Novartis) for the treatment of adults with relapsing forms of multiple sclerosis, including...

Ofatumumab Shows High Elimination of Disease Activity in MS

With ofatumumab (Arzerra, Novartis), a fully human anti-CD20 monoclonal antibody, there is a greater likelihood of there being no evidence of disease activity (NEDA-3) for...

High Levels of Air Pollution Linked to Increased MS Risk

Air pollution may be another environmental risk factor for developing multiple sclerosis (MS), new research suggests. A large cohort study of almost 550,000 individuals living...

Initial High-Efficacy MS Therapy Tied to Less Disability Later

Starting treatment for relapsing-remitting multiple sclerosis (MS) with high-efficacy therapy (HET) is associated with lower long-term disability compared with a step-wise increase to reach more...